CHE SEC-Einreichungen - Chemed Corporation- Jahresbericht, Proxy Statement, Prospekt

Basisstatistiken

LEI	54930020031IDJT2IM79
CIK	19584

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Chemed Corporation

SEC Filings (Chronological Order)

Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.

May 19, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 18, 2026 CHEMED CORPORATION ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 18, 2026 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Num
April 28, 2026	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2026 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 23, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 23, 2026 CHEMED CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 23, 2026 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 23, 2026	EX-99	Chemed Reports First-Quarter 2026 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports First-Quarter 2026 Results Full-Year Guidance Increased Due To: · Strong VITAS Performance · Re-purchase of 500,000 Shares in the Quarter · Two Roto-Rooter Franchises Purchased for $20.6 Million CINCINNATI, April 23, 2026—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s larg
April 13, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 10, 2026 CHEMED CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 10, 2026 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdict
April 13, 2026	EX-99.1	Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement CONTACT: Michael D. Witzeman FOR IMMEDIATE RELEASE (513) 762-6714 Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement CINCINNATI, April 13, 2026-Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility (“Credit Agreement”). JPMorgan Chase Bank, N.A., acted as the Admini
April 13, 2026	EX-10.1	___________________________________________________________________________ SIXTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 10, 2026 among CHEMED CORPORATION the Lenders Party Hereto, BANK OF AMERICA, N.A., as Syndication Agent and Join SIXTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 10, 2026 among CHEMED CORPORATION the Lenders Party Hereto, BANK OF AMERICA, N.
April 9, 2026	DEFR14A	Important Notice Regarding the Availability of Proxy Materials ‎for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as pe
April 6, 2026	DEF 14A	Important Notice Regarding the Availability of Proxy Materials ‎for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as perm
February 27, 2026	EX-10.29	Chemed Corporation Form of Stock Option Grant - 2025 EXHIBIT 10.29 Chemed Corporation Form of Stock Option Grant - 2025 Name Address City, State ZIP Code Dear , In accordance with the 2025 Stock Incentive Plan (the “Plan”) of Chemed Corporation (the “Corporation”), you are hereby granted an option to purchase shares of the capital stock, par value $1.00 per share, of the Corporation upon the following terms and conditions. (1) The purchase pri
February 27, 2026	EX-24	POWER OF ATTORNEY EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 27, 2026	EX-21	SUBSIDIARIES OF CHEMED CORPORATION EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2025: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 27, 2026	EX-10.20	CHEMED CORPORATION SENIOR EXECUTIVE SEVERANCE POLICY AS AMENDED AUGUST 3, 2018 CHEMED CORPORATION SENIOR EXECUTIVE SEVERANCE POLICY AS AMENDED AUGUST 3, 2018 As of December 1, 2006, Chemed Corporation established the Chemed Corporation Senior Executive Severance Policy (“the Policy”).
February 27, 2026	EX-10.19	CHEMED CORPORATION CHANGE IN CONTROL SEVERANCE PLAN AS AMENDED AUGUST 3, 2018 CHEMED CORPORATION CHANGE IN CONTROL SEVERANCE PLAN AS AMENDED AUGUST 3, 2018 ARTICLE I ESTABLISHMENT and amendment OF PLAN As of the Effective Date, the Company (as such term is hereinafter defined) established the Chemed Corporation Change in Control Severance Plan, as set forth in this document.
February 27, 2026	10-K	FORM 10-K M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact nam
February 27, 2026	EX-97	Incentive Compensation Recovery Policy EXHIBIT 97 Incentive Compensation Recovery Policy A. PURPOSE This Incentive Compensation Recovery Policy (this “Recovery Policy”) is adopted by Chemed Corporation, a Delaware corporation (the “Company”), as of the 3rd day of November, 2023 (the “Effective Date”) as required by Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 under the Exchange Act
February 25, 2026	EX-99	Chemed Reports Fourth-Quarter 2025 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Fourth-Quarter 2025 Results CINCINNATI, February 25, 2026—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial re
February 25, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2026 CHEMED CORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2026 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fil
October 31, 2025	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2025 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 28, 2025	EX-99	Chemed Reports Third-Quarter 2025 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Third-Quarter 2025 Results CINCINNATI, October 28, 2025—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial resul
October 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 28, 2025 CHEMED CORPORATI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 28, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
September 29, 2025	144	144 144 0001207137 XXXXXXXX LIVE 0000019584 Chemed Corp 001-08351 255 E 5th St, Ste 2600 Cincinnati OH 45206 5137626690 Kevin McNamara Officer Chemed Corporation Merrill Lynch 5905 E.
September 26, 2025	144	144 144 0001207137 XXXXXXXX LIVE 0000019584 CHEMED CORP 001-08351 SUITE 2600 255 E FIFTH ST CINCINNATI OH 45202 (513)762-6690 MCNAMARA KEVIN J Officer Director Common Raymond James & Associates, Inc.
September 9, 2025	144	144 144 0001230970 XXXXXXXX LIVE 0000019584 Chemed Corporation 001-08351 255 E. Fifth Street, Suite 2600 Cincinnati OH 45202 513-762-6690 Patrick P. Grace Director Capital Stock J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017 150 69567 14571695 09/09/2025 NYSE Capital Stock 05/29/2025 Executive Compensation Issuer N 277 05/29/2025 Compensation Y 09/09/2025 /s/ J.P. Morgan Se
July 31, 2025	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2025 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 31, 2025	EX-10.1	Nicholas M. Westfall Transition and Separation Agreement EXHIBIT 10.1 TRANSITION AND SEPARATION AGREEMENT AND GENERAL RELEASE This Transition and Separation Agreement and General Release (“Agreement”) is entered into by on the one hand, Nicholas M. Westfall, an individual, (“Executive”), and, on the other hand, Chemed Corporation, along with each and all of its subsidiaries, divisions, affiliates, joint ventures, officers, directors, employees and other
July 29, 2025	EX-99	Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure CINCINNATI, July 29, 2025—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain
July 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2025 CHEMED CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Nu
June 27, 2025	11-K	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) x Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024 ¨ Transition Report Pursuant
June 27, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 27, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Nu
June 27, 2025	EX-99	Chemed To Report Second-Quarter 2025 Earnings July 29, 2025 Provides Current Update to 2025 Earnings Performance Related Conference Call to Be Held On July 30, 2025 CONTACT: Michael D. Witzeman FOR IMMEDIATE RELEASE (513) 762-6714 Chemed To Report Second-Quarter 2025 Earnings July 29, 2025 Provides Current Update to 2025 Earnings Performance Related Conference Call to Be Held On July 30, 2025 CINCINNATI, June 27, 2025-Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesda
June 27, 2025	EX-1	Exhibit I EXHIBIT I CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (File No.
May 22, 2025	S-8 POS	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO 1. FORM S-8 As filed with the Securities and Exchange Commission on May 20, 2025 Registration No.
May 20, 2025	EX-4.6	2025 Stock Incentive Plan EXHIBIT 4.6 Chemed Corporation 2025 Stock Incentive Plan 1. Purpose. The purpose of the Plan is to support the Company’s ongoing efforts to develop and retain excellent Key Employees and to provide them with incentives that are directly linked to the profitability of the Company’s businesses and to increases in stockholder value. 2. Definitions. For purposes of the Plan, the following terms ar
May 20, 2025	S-8	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 255 E. Fifth Street, Suite 2600, Cincinnati, Ohio 45202 (Addre
May 20, 2025	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Num
May 20, 2025	EX-4.7	Form of Option Grant EXHIBIT 4.7 Name Address City, State ZIP Code Dear , In accordance with the Stock Incentive Plan (the “Plan”) of Chemed Corporation (the “Corporation”), you are hereby granted an option to purchase shares of the capital stock, par value $1.00 per share, of the Corporation upon the following terms and conditions. (1) The purchase price shall be $ per share. Payment thereof shall be made in ca
May 20, 2025	EX-FILING FEES	Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 CHEMED CORP Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $1 per share Other 1,100,000 $ 555.
May 20, 2025	EX-4.8	Form of Performance Based Stock Award EXHIBIT 4.8 February 14, 2025 Name Address Dear : I am pleased to inform you that the Compensation/Incentive Committee (the “Committee”) of Chemed Corporation (the "Company"), has granted you a target number of share units, which are the equivalent of one share of the Company's Capital Stock ("Capital Stock"), par value $1.00 per share (“Performance Share Units”), u
May 20, 2025	EX-24	Power of Attorney EXHIBIT 24 EXHIBIT 24 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned, a Director of Chemed Corporation, hereby constitutes and appoints Kevin J.
April 28, 2025	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2025 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 23, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 23, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 23, 2025	EX-99	Chemed Reports First-Quarter 2025 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports First-Quarter 2025 Results CINCINNATI, April 23, 2025—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financi
April 7, 2025	DEF 14A	Important Notice Regarding the Availability of Proxy Materials ‎for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as perm
April 1, 2025	10-K/A	FORM 10-K/A M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact n
February 28, 2025	EX-19	Insider Trading Policy of Chemed Corporation EXHIBIT 19 INSIDER TRADING POLICY A. INTRODUCTION AND STATEMENT OF PRINCIPLES 1. Chemed Corporation and its subsidiaries or affiliates (collectively, the “Company”) are subject to and shall promote compliance with U.S. federal and state securities laws, including insider trading laws, rules and regulations promulgated by the U.S. Securities and Exchange Commission (the “SEC”), and any appl
February 28, 2025	EX-24	Powers of Attorney EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 28, 2025	EX-97	Compensation Recovery Policy EXHIBIT 97 Incentive Compensation Recovery Policy A. PURPOSE This Incentive Compensation Recovery Policy (this “Recovery Policy”) is adopted by Chemed Corporation, a Delaware corporation (the “Company”), as of the 3rd day of November, 2023 (the “Effective Date”) as required by Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 under the Exchange A
February 28, 2025	10-K	FORM 10-K M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact nam
February 28, 2025	EX-21	Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2024: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 26, 2025	EX-99	Chemed Reports Fourth-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Fourth-Quarter 2024 Results CINCINNATI, February 26, 2025—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported finan
February 26, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 26, 2025 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fil
November 1, 2024	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2024 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 29, 2024	EX-99	Chemed Reports Third-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Third-Quarter 2024 Results CINCINNATI, October 29, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financi
October 29, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
July 26, 2024	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2024 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 24, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 24, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Nu
July 24, 2024	EX-99	Chemed Reports Second-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Second-Quarter 2024 Results CINCINNATI, July 24, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial
June 26, 2024	11-K	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) x Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 ¨ Transition Report Pursuant
June 26, 2024	EX-1	Exhibit I EXHIBIT I CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (File No.
June 26, 2024	EX-2	Exhibit II EXHIBIT II CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (No.
May 21, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 20, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Num
April 29, 2024	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2024 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 24, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 24, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 24, 2024	EX-99	Chemed Reports First-Quarter 2024 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports First-Quarter 2024 Results CINCINNATI, April 24, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial
April 17, 2024	EX-99.1	VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama CONTACT: Michael D. Witzeman (513) 762-6714 VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama CINCINNATI, April 17, 2024 – VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility f
April 17, 2024	8-K	Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 17, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 8, 2024	DEF 14A	Important Notice Regarding the Availability of Proxy Materials ‎for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as perm
March 13, 2024	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 13, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
March 13, 2024	EX-99.1	VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama CONTACT: Michael D. Witzeman (513) 762-6714 VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama CINCINNATI, March 13, 2024 – VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Co
February 29, 2024	10-K	FORM 10-K M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact nam
February 29, 2024	EX-21	Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2023: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 29, 2024	EX-24	Powers of Attorney EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 29, 2024	EX-97	Compensation Recovery Policy EXHIBIT 97 Incentive Compensation Recovery Policy A. PURPOSE This Incentive Compensation Recovery Policy (this “Recovery Policy”) is adopted by Chemed Corporation, a Delaware corporation (the “Company”), as of the 3rd day of November, 2023 (the “Effective Date”) as required by Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 under the Exchange A
February 27, 2024	EX-99	Chemed Reports Fourth-Quarter 2023 Results CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Reports Fourth-Quarter 2023 Results CINCINNATI, February 27, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported fin
February 27, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 27, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fil
February 13, 2024	SC 13G/A	CHE / Chemed Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 15)* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1
February 1, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 1, 2024 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
February 1, 2024	EX-10.1	David P. Williams Performance Share Units Grant Letter dated January 29, 2024 January 29, 2024 Dear Mr. Williams: In connection with your transition from Chief Financial Officer and Executive Vice President of Chemed Corporation (the “Company”) to an employee in an advisory role to the Chief Executive Officer, I am please to inform you that you have been granted a target number of 6,424 share units, which are the equivalent of one share of the Comp
January 24, 2024	SC 13G/A	CHE / Chemed Corporation / BlackRock Inc. Passive Investment SC 13G/A 1 us16359r1032012424.txt us16359r1032012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) CHEMED CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 16359R103 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des
December 18, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 18, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fil
December 18, 2023	EX-99.1	Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO CINCINNATI, December 18, 2023-Chemed Corporation (NYSE: CHE) – Today Chemed Corporation’s Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzema
November 3, 2023	EX-99.1	Chemed Corporation Announces the Retirement of David P. Williams CONTACT: Michael D. Witzeman (513) 762-6714 Chemed Corporation Announces the Retirement of David P. Williams CINCINNATI, November 3, 2023-Chemed Corporation (NYSE: CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed’s Chief Financial Officer as of December 31, 2023, but Mr. Williams will co
November 3, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 3, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
October 30, 2023	LETTER	LETTER United States securities and exchange commission logo October 30, 2023 David Williams Executive Vice President and Chief Financial Officer CHEMED CORP 255 E.
October 27, 2023	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2023 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 27, 2023	CORRESP	October 27, 2023 October 27, 2023 Ms. Tracey Houser and Ms. Jeanne Baker United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2022 Filed February 27, 2023 Response Letter Dated October 16, 2023 File No. 001-08351 Dear Ms. Houser and Ms. B
October 25, 2023	EX-99	Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance CINCINNATI, October 25, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning servic
October 25, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 30, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fi
October 23, 2023	LETTER	LETTER United States securities and exchange commission logo October 23, 2023 David Williams Executive Vice President and Chief Financial Officer CHEMED CORP 255 E.
October 16, 2023	CORRESP	October 16, 2023 October 16, 2023 Ms. Tracey Houser and Ms. Jeanne Baker United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2022 Filed February 27, 2023 File No. 001-08351 Dear Ms. Houser and Ms. Baker: On behalf of Chemed Corporation (
October 5, 2023	LETTER	LETTER United States securities and exchange commission logo October 5, 2023 David Williams Executive Vice President and Chief Financial Officer CHEMED CORP 255 E.
July 28, 2023	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2023 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 30, 2023 CHEMED CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 30, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Nu
July 26, 2023	EX-99	Chemed Reports Second-Quarter 2023 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Second-Quarter 2023 Results CINCINNATI, July 26, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial res
June 28, 2023	11-K	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) x Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 ¨ Transition Report Pursuant
June 28, 2023	EX-1	Exhibit I EXHIBIT 1 We consent to the incorporation by reference in the Registration Statement (Nos.
May 16, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 15, 2023 CHEMED CORPORATION ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 15, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Num
April 28, 2023	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2023 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 26, 2023	EX-99	Chemed Reports First-Quarter 2023 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports First-Quarter 2023 Results CINCINNATI, April 26, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial r
April 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 31, 2023 CHEMED CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 31, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 6, 2023	ARS	CHEMED CORP (FORM ARS) C HEMED C ORPO RA TIO N 255 East Fifth Street Suite 2600 Cincinnati, Ohio 45202-4726 2022 ANNU AL REPO R T w w w.
April 6, 2023	DEF 14A	Important Notice Regarding the Availability of Proxy Materials ‎for the ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as perm
February 27, 2023	EX-10.29	Form of Stock Option Grant - 2022 Exhibit 10.29 Chemed Corporation Form of Stock Option Grant – 2022 Date Name Address City, State ZIP Code Dear , In accordance with the 2022 Stock Incentive Plan (the “Plan”) of Chemed Corporation (the “Corporation”), you are hereby granted an option to purchase shares of the capital stock, par value $1.00 per share, of the Corporation upon the following terms and conditions. (1) The purchas
February 27, 2023	EX-24	Powers of Attorney EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 27, 2023	EX-21	Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2022: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 27, 2023	10-K	FORM 10-K M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact nam
February 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2023 CHEMED CORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2023 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fil
February 23, 2023	EX-99	Chemed Reports Fourth-Quarter 2022 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Fourth-Quarter 2022 Results CINCINNATI, February 23, 2023—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported finan
February 9, 2023	SC 13G/A	CHE / Chemed Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: Chemed Corp. Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule
January 24, 2023	SC 13G	CHE / Chemed Corporation / BlackRock Inc. Passive Investment SC 13G 1 us16359r1032012423.txt us16359r1032012423.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) CHEMED CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 16359R103 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design
December 9, 2022	EX-3.1	Amended and Restated By-Laws of Chemed Corporation, effective as of December 9, 2022 BY-LAWS of CHEMED CORPORATION (As amended through December 9, 2022) AMENDED AND RESTATED BY-LAWS of CHEMED CORPORATION (a Delaware Corporation) ARTICLE I Meeting of Stockholders Section 1.
December 9, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 9, 2022 CHEMED CORPORATI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 9, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
November 7, 2022	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation
November 2, 2022	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 31, 2022	EX-99	Chemed Reports Third-Quarter 2022 Results – Increases 2022 Earnings Guidance ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports Third-Quarter 2022 Results ? Increases 2022 Earnings Guidance ? CINCINNATI, October 31, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning
October 31, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 31, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File
August 5, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File N
July 29, 2022	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 27, 2022	EX-99	Chemed Reports Second-Quarter 2022 Results ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports Second-Quarter 2022 Results ? CINCINNATI, July 27, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial
July 27, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Nu
June 29, 2022	EX-99.1	(513) 762-6901 ? ? ? CONTACT: David P. Williams FOR IMMEDIATE RELEASE (513) 762-6901 ? ? Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility ? ? CINCINNATI, June 29, 2022-Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into $550 million of amended and restated senior secured credit facilities (?Credit Facilities?). JPMorgan Chase Bank,
June 29, 2022	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 29, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdicti
June 29, 2022	EX-10.1	Fifth Amended and Restated Credit Agreement by and among Chemed Corporation, JP Morgan Chase Bank NA, and other lenders as of June 28, 2022 FIFTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of June 28, 2022 among CHEMED CORPORATION the Lenders Party Hereto, BANK OF AMERICA, N.
June 23, 2022	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 11-K 1 a52760217.htm CHEMED CORPORATION 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ☒ Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021
May 17, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 17, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Num
May 16, 2022	EX-24	Powers of Attorney Exhibit 24 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned, a Director of Chemed Corporation, hereby constitutes and appoints Kevin J.
May 16, 2022	S-8	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMED CORPORATION (Exact name of registrant as specified in its charter) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 255 E. Fifth Street, Suite 2600, Cincinnati, Ohio 45202 (Address of principal ex
May 16, 2022	EX-4.6	2022 Stock Incentive Plan Exhibit 4.6 Chemed Corporation 2022 Stock Incentive Plan 1. Purpose. The purpose of the Plan is to support the Company?s ongoing efforts to develop and retain excellent Key Employees and to provide them with incentives that are directly linked to the profitability of the Company?s businesses and to increases in stockholder value. 2. Definitions. For purposes of the Plan, the following terms are de
May 16, 2022	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Chemed Corporation (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities Security Type Security Class Type Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $1.
April 29, 2022	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2022 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 26, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 26, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File N
April 26, 2022	EX-99	Chemed Reports First-Quarter 2022 Results ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports First-Quarter 2022 Results ? CINCINNATI, April 26, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial
April 8, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (a
February 28, 2022	EX-21	Subsidiaries of Chemed Corporation EXHIBIT 21 ? SUBSIDIARIES OF CHEMED CORPORATION ? The following is a list of subsidiaries of the Company as of December 31, 2021: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 28, 2022	EX-10.19	Change in Control Severance Plan as amended August 3, 2018 EXHIBIT 10.19 CHEMED CORPORATION CHANGE IN CONTROL SEVERANCE PLAN AS AMENDED AUGUST 3, 2018 ESTABLISHMENT and amendment OF PLAN As of the Effective Date, the Company (as such term is hereinafter defined) established the Chemed Corporation Change in Control Severance Plan, as set forth in this document. As of the Amendment Date, the Company amended the Plan to provide that the tax gross-up provisio
February 28, 2022	10-K	FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name
February 28, 2022	EX-10.20	Senior Executive Severance Policy as amended August 3, 2018 ‎ EXHIBIT 10.20 CHEMED CORPORATION SENIOR EXECUTIVE SEVERANCE POLICY AS AMENDED AUGUST 3, 2018 As of December 1, 2006, Chemed Corporation established the Chemed Corporation Senior Executive Severance Policy (?the Policy?). As of August 3, 2018 (the "Amendment Date"), the Company amended the Policy to provide that the tax gross-up provisions in Section 3.1 shall apply only to those individuals who we
February 28, 2022	EX-24	Powers of Attorney EXHIBIT 24 ? POWER OF ATTORNEY ? The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 24, 2022	EX-99	Chemed Reports Fourth-Quarter 2021 Results ? CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports Fourth-Quarter 2021 Results ? CINCINNATI, February 24, 2022?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported finan
February 24, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 24, 2022 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission Fil
February 9, 2022	SC 13G/A	CHE / Chemed Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Chemed Corp. Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule
February 1, 2022	SC 13G/A	CHE / Chemed Corporation / BlackRock Inc. Passive Investment us16359r1032013122.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 13) CHEMED CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 16359R103 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
November 1, 2021	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 28, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 28, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File
October 28, 2021	EX-99	Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased EX-99 2 che-20211028xex99.htm EX-99 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased CINCINNATI, October 28, 2021—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercia
July 30, 2021	10-Q	CHEMED CORPORATION AND UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 27, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Nu
July 27, 2021	EX-99	Chemed Reports Second-Quarter 2021 Results – Full-Year 2021 Guidance Increased EX-99 2 che-20210727xex99.htm EX-99 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Second-Quarter 2021 Results – Full-Year 2021 Guidance Increased CINCINNATI, July 27, 2021—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and resid
June 21, 2021	11-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K/A For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K/A For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ? Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 ? Transition Report Pursuant to Section 13
June 17, 2021	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ? Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 ? Transition Report Pursuant to Section 13 o
May 19, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File Num
April 30, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 27, 2021	PX14A6G	- Chemed Corporation (CHE) Shareholder Alert Voluntary submission by John Chevedden, POB 2673, Redondo Beach, CA 90278 Chemed Corporation Shareholder since 2015 Please support proposal topic that won our 48% support in 2020 Political Spending Disclosure A 48% vote means that that the shares that had access to objective voting advice were more than 50% in favor.
April 27, 2021	EX-99	Chemed Reports First-Quarter 2021 Results CONTACT: David P. Williams (513) 762-6901 ? Chemed Reports First-Quarter 2021 Results ? CINCINNATI, April 27, 2021?Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation?s largest providers of end-of-life care, and Roto-Rooter, the nation?s largest commercial and residential plumbing and drain cleaning services provider, reported financial r
April 27, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission File N
April 9, 2021	DEF 14A	- CHEMED CORP. DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (a
February 26, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name
February 26, 2021	EX-21	Subsidiaries of Chemed Corporation EXHIBIT 21 ? SUBSIDIARIES OF CHEMED CORPORATION ? The following is a list of subsidiaries of the Company as of December 31, 2020: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 26, 2021	EX-24	Powers of Attorney EXHIBIT 24 ? POWER OF ATTORNEY ? The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 23, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2021 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ?jurisdiction of ?incorporation) (Commission Fil
February 23, 2021	EX-99	Chemed Reports Fourth-Quarter 2020 Results EX-99 2 che-20210223xex99.htm EX-99 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Fourth-Quarter 2020 Results CINCINNATI, February 23, 2021—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleani
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Chemed Corp. Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule
January 29, 2021	SC 13G/A	SC 13G/A us16359r1032012821.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 12) CHEMED CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 16359R103 - (CUSIP Number) December 31, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
December 4, 2020	TEXT-EXTRACT	- United States securities and exchange commission logo December 4, 2020 Brian Judkins, Esq.
December 4, 2020	LETTER	LETTER United States securities and exchange commission logo December 4, 2020 Brian Judkins, Esq.
November 30, 2020	CORRESP	- November 30, 2020 Mr. Tim Buchmiller and Ms. Celeste Murphy United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2019 Filed February 26, 2020 File No. 001-08351 Dear Mr. Buchmiller and Ms. Murphy: On behalf of Chemed Corporation (the “Company”)
November 17, 2020	TEXT-EXTRACT	- United States securities and exchange commission logo November 16, 2020 Brian Judkins, Esq.
November 17, 2020	LETTER	LETTER United States securities and exchange commission logo November 16, 2020 Brian Judkins, Esq.
November 4, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 29, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
October 29, 2020	EX-99	Chemed Reports Third-Quarter 2020 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2020 Results CINCINNATI, October 29, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financi
September 1, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 31, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
July 31, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 30, 2020	EX-99	Chemed Reports Second-Quarter 2020 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports Second-Quarter 2020 Results CINCINNATI, July 29, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial r
July 30, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Nu
June 18, 2020	11-K	- CHEMED CORPORATION 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934 (Mark One) ☒ Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019 ☐ Transition Report Pursuant to Section 13 o
May 19, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 18, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File Num
May 1, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 28, 2020	EX-99	Chemed Reports First-Quarter 2020 Results CONTACT: David P. Williams (513) 762-6901 Chemed Reports First-Quarter 2020 Results CINCINNATI, April 28, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial
April 28, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 28, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 22, 2020	DEFA14A	CHE / Chemed Corp. DEFA14A - - CHEMED CORP. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a
April 22, 2020	EX-99.1	Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting CONTACT: David P. Williams (513) 762-6901 Chemed Corporation Announces Virtual 2020 Annual Stockholder Meeting CINCINNATI, April 22, 2020-Chemed Corporation (NYSE:CHE) announced today that the Company will hold its 2020 Annual Meeting of Stockholders in a virtual-only format due to public health concerns relating to the coronavirus (COVID-19) and to protect the health and well-being of its sto
April 22, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 22, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 15, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 15, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
April 9, 2020	DEF 14A	CHE / Chemed Corp. DEF 14A - - CHEMED CORPORATION DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a
March 13, 2020	EX-99.1	Chemed Corporation’s Board of Directors Authorizes an Additional $250 Million for Stock Repurchase Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Chemed Corporation’s Board of Directors Authorizes an Additional $250 Million for Stock Repurchase CINCINNATI, March 13, 2020-Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $250 million for stock repurchase under Chemed’s existing share repurchase program. These share repurch
March 13, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 13, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
February 26, 2020	EX-4.1	Description of Securities EXHIBIT 4.1 Description of the Company’s Capital Stock The following description of Chemed Corporation’s capital stock is based on and qualified by the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), and our By-laws, as amended (the “By-laws”). This description does not purport to be complete, or to give full effect to the provisions of statutory or com
February 26, 2020	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name
February 26, 2020	EX-21	Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2019: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 26, 2020	EX-24	Powers of Attorney EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 26, 2020	EX-10.29	Form of Stock Option Grant - 2018 Exhibit 10.29 Chemed Corporation Form of Stock Option Grant - 2019 Name Address City, State ZIP Code Dear , In accordance with the 2018* Stock Incentive Plan (the “Plan”) of Chemed Corporation (the “Corporation”), you are hereby granted an option to purchase 2018 shares of the capital stock, par value $1.00 per share, of the Corporation upon the following terms and conditions. (1) The purchase
February 18, 2020	EX-99	Chemed Reports Fourth-Quarter 2019 Results Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Fourth-Quarter 2019 Results CINCINNATI, February 18, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider,
February 18, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 18, 2020 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fil
February 12, 2020	SC 13G/A	CHE / Chemed Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1
February 5, 2020	SC 13G/A	CHE / Chemed Corp. / BlackRock Inc. Passive Investment us16359r1032020420.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) CHEMED CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 16359R103 - (CUSIP Number) December 31, 2019 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
November 4, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2019 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 30, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File
October 30, 2019	EX-99	Chemed Reports Third-Quarter 2019 Results Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Chemed Reports Third-Quarter 2019 Results CINCINNATI, October 29, 2019—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, repor
September 17, 2019	EX-99.1	Roto-Rooter Completes the Previously Announced Purchase of Assets of Its Largest Independent Franchise Operator Exhibit 99.1 CONTACT: David P. Williams (513) 762-6901 Roto-Rooter Completes the Previously Announced Purchase of Assets of Its Largest Independent Franchise Operator CINCINNATI, September 16, 2019 – Roto-Rooter Services Company, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced the completion of the previously announced purchase of HSW RR, Inc.’s (“HSW”) franchise
September 17, 2019	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 17, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission Fi
August 5, 2019	EX-99.1	Chemed Corporation Releases Updated Guidance CONTACT: David P. Williams (513) 762-6901 Chemed Corporation Releases Updated Guidance CINCINNATI, August 5, 2019-The VITAS and Chemed (NYSE:CHE) updated guidance includes the increase and rebasing of hospice reimbursement rates announced by CMS on July 31, 2019, and effective October 1, 2019. This updated guidance also includes certain increased costs related to revenue pass-through under cer
August 5, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other ‎jurisdiction of ‎incorporation) (Commission File N
August 5, 2019	EX-99.2	Roto-Rooter To Buy Assets of Its Largest Independent Franchise Operator CONTACT: David P. Williams (513) 762-6901 Roto-Rooter To Buy Assets of Its Largest Independent Franchise Operator CINCINNATI, August 5, 2019 – Roto-Rooter Services Company, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has entered into an agreement to acquire all of HSW RR, Inc.’s (“HSW”) franchise operations and Western Drain Supply for an aggregate purch
July 31, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2019 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 25, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdicti
July 25, 2019	EX-99	Chemed Reports Second-Quarter 2019 Results Exhibit 99 Chemed Reports Second-Quarter 2019 Results CINCINNATI-(BUSINESS WIRE)-July 25, 2019-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2019, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 7.
June 26, 2019	11-K	11-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT [X] PURSUANT TO SECTON 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 [] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) CHEMED/ROTO-ROOTER SA VINOS & RETIREMENT PLAN (Full title of the plan) Chemed Corporation (Name of iss
May 22, 2019	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 20, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1‑8351 31‑0791746 (State or other (Commission File Number) (I.R.S. Employer jurisdictio
May 2, 2019	10-Q	Quarterly Report - CHEMED CORP. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2019 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 29, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51973296.htm CHEMED CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 29, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdic
April 29, 2019	EX-99	Chemed Reports First-Quarter 2019 Results Exhibit 99 Chemed Reports First-Quarter 2019 Results CINCINNATI-(BUSINESS WIRE)-April 29, 2019-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2019, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 5.
April 9, 2019	DEF 14A	CHE / Chemed Corp. CHEMED CORP. DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a
February 27, 2019	EX-24	Powers of Attorney EXHIBIT 24 POWER OF ATTORNEY The undersigned director of CHEMED CORPORATION ("Company") hereby appoints KEVIN J.
February 27, 2019	10-K	CHE / Chemed Corp. CHEMED CORP. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number: 1-8351 CHEMED CORPORATION (Exact name
February 27, 2019	EX-21	Subsidiaries of Chemed Corporation EXHIBIT 21 SUBSIDIARIES OF CHEMED CORPORATION The following is a list of subsidiaries of the Company as of December 31, 2018: Other subsidiaries which have been omitted from the list would not, when considered in the aggregate, constitute a significant subsidiary.
February 27, 2019	EX-10.19	Plan as amended August 3, 2018. EXHIBIT 10.19 CHEMED CORPORATION CHANGE IN CONTROL SEVERANCE PLAN AS AMENDED AUGUST 3, 2018 ESTABLISHMENT AND AMENDMENT OF PLAN As of the Effective Date, the Company (as such term is hereinafter defined) established the Chemed Corporation Change in Control Severance Plan, as set forth in this document. As of the Amendment Date, the Company amended the Plan to provide that the tax gross-up provisio
February 27, 2019	EX-13	2018 Annual Report to Stockholders EXHIBIT 13 Financial Review Contents Report of Independent Registered Public Accounting Firm 61 Consolidated Statements of Income 63 Consolidated Balance Sheets 64 Consolidated Statements of Cash Flows 65 Consolidated Statements of Changes in Stockholders’ Equity 66 Notes to Consolidated Financial Statements 67 Unaudited Summary of Quarterly Results 93 Selected Financial Data 95 Unaudited Consolid
February 27, 2019	EX-10.20	Policy as amended August 3, 2018. EXHIBIT 10.20 CHEMED CORPORATION SENIOR EXECUTIVE SEVERANCE POLICY AS AMENDED AUGUST 3, 2018 As of December 1, 2006, Chemed Corporation established the Chemed Corporation Senior Executive Severance Policy (“the Policy”). As of August 3, 2018 (the "Amendment Date"), the Company amended the Policy to provide that the tax gross-up provisions in Section 3.1 shall apply only to those individuals who we
February 25, 2019	EX-99	Chemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock Repurchase Exhibit 99 Chemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock Repurchase CINCINNATI-(BUSINESS WIRE)-February 25, 2019-Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $150 million for stock repurchase under Chemed’s existing share repurchase program.
February 25, 2019	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File
February 20, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 20, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File
February 20, 2019	EX-99	Chemed Reports Fourth-Quarter 2018 Results Exhibit 99 Chemed Reports Fourth-Quarter 2018 Results CINCINNATI-(BUSINESS WIRE)-February 20, 2019-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2018, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6.
February 13, 2019	SC 13G/A	CHE / Chemed Corp. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* CHEMED CORPORATION (Name of Issuer) Common (Title of Class of Securities) 16359R103 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th
February 11, 2019	SC 13G/A	CHE / Chemed Corp. / VANGUARD GROUP INC Passive Investment chemedcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10 )* Name of issuer: Chemed Corp Title of Class of Securities: Common Stock CUSIP Number: 16359R103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to designate
January 24, 2019	SC 13G/A	CHE / Chemed Corp. / BlackRock Inc. Passive Investment us16359r1032012419.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) CHEMED CORP - (Name of Issuer) Common Stock - (Title of Class of Securities) 16359R103 - (CUSIP Number) December 31, 2018 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
December 11, 2018	LETTER	LETTER December 11, 2018 David Williams Executive Vice President and Chief Financial Officer Chemed Corporation 255 East Fifth Street Suite 2600 Cincinnati, OH 45202 Re: Chemed Corporation Form 10-K for the Year Ended December 31, 2017 Filed February 26, 2018 File No.
December 11, 2018	TEXT-EXTRACT	CHE / Chemed Corp. TEXT-EXTRACT December 11, 2018 David Williams Executive Vice President and Chief Financial Officer Chemed Corporation 255 East Fifth Street Suite 2600 Cincinnati, OH 45202 Re: Chemed Corporation Form 10-K for the Year Ended December 31, 2017 Filed February 26, 2018 File No.
December 6, 2018	CORRESP	CHE / Chemed Corp. CORRESP December 6, 2018 Mr. Craig Arakawa, Accounting Branch Chief United States Securities and Exchange Commission Division of Corporation Finance Office of Beverages, Apparel and Mining 100 F Street, N.E. Washington, D.C. 20549 Re: Chemed Corp. Form 10-K for Fiscal Year Ended December 31, 2017 Filed February 26, 2018 File No. 001-08351 Dear Mr. Arakawa: On behalf of Chemed Corporation (“Chemed” or the
November 29, 2018	LETTER	LETTER November 29, 2018 David Williams Executive Vice President and Chief Financial Officer Chemed Corporation 255 East Fifth Street Suite 2600 Cincinnati, OH 45202 Re: Chemed Corporation Form 10-K for the Year Ended December 31, 2017 Filed February 26, 2018 File No.
November 29, 2018	TEXT-EXTRACT	CHE / Chemed Corp. TEXT-EXTRACT November 29, 2018 David Williams Executive Vice President and Chief Financial Officer Chemed Corporation 255 East Fifth Street Suite 2600 Cincinnati, OH 45202 Re: Chemed Corporation Form 10-K for the Year Ended December 31, 2017 Filed February 26, 2018 File No.
November 2, 2018	10-Q	CHE / Chemed Corp. CHEMED CORP. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as sp
October 29, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File N
October 29, 2018	EX-99	Chemed Reports Third-Quarter 2018 Results - Earnings Guidance Increased Exhibit 99 Chemed Reports Third-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI-(BUSINESS WIRE)-October 29, 2018-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2018, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6.
October 1, 2018	EX-99	Roto-Rooter Buys Five Northern California Franchises – Acquisition is the Company’s Largest to Date Exhibit 99 Roto-Rooter Buys Five Northern California Franchises – Acquisition is the Company’s Largest to Date CINCINNATI-(BUSINESS WIRE)-October 1, 2018-Chemed Corporation ("Chemed") (NYSE:CHE) today announced its Roto-Rooter Services Company subsidiary has acquired five formerly independent Roto-Rooter franchises covering several areas of Northern California.
October 1, 2018	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 1, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Nu
July 30, 2018	10-Q	CHE / Chemed Corp. CHEMED CORP. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specifi
July 25, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Numb
July 25, 2018	EX-99	Chemed Reports Second-Quarter 2018 Results - Earnings Guidance Increased Exhibit 99 Chemed Reports Second-Quarter 2018 Results - Earnings Guidance Increased CINCINNATI-(BUSINESS WIRE)-July 25, 2018-Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2018, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6.
June 22, 2018	8-K	Entry into a Material Definitive Agreement 8-K 1 a51826107.htm CHEMED CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 20, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1‑8351 31‑0791746 (State or other (Commission Fil
June 22, 2018	EX-10.1	As of June 20, 2018 exhibits and schedules thereto. EX-10.1 2 a51826107ex101.htm EXHIBIT 10.1 Exhibit 10.1 J.P. Morgan FOURTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of June 20, 2018 among CHEMED CORPORATION the Lenders Party Hereto, BANK OF AMERICA, N.A., as Syndication Agent, U.S. BANK NATIONAL ASSOCIATION, as Documentation Agent and JPMORGAN CHASE BANK, N.A., as Administrative Agent JPMORGAN CHASE BANK, N.A. and MERRILL LYNCH, PIERCE, FEN
June 22, 2018	EX-99.1	Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement EX-99.1 3 a51826107ex991.htm EXHIBIT 99.1 Exhibit 99.1 Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement CINCINNATI-(BUSINESS WIRE)-June 21, 2018-Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility (“Credit Agreement”). JPMorgan Chase Bank, N.A., acted as the Administr
June 20, 2018	LETTER	LETTER DAVID J. LOHBECK Vice President Health, Welfare and Financial Benefits Securities and Exchange Commission Attention: Filing Desk, Stop 1-4 Room 1004 450 Fifth Street, N.W. Washington, DC 20549-1004 RE: 2017 Form 11-K ROTO OOTER* PLUMBING & DRAIN SERVICE Receipt Acknowledged: Rote-Rooter Services Company Suite 2500 255 East 5th Street Cincinnati, OH 45202-4725 513.762.6870 Phone 513.762.6662 Fax da
June 13, 2018	11-K	11-K SECURITIES AND EXCHANGE COMMlSSION WASHINGTON, D.C. 20549 essing J SEC Mail Processing JUN 1 3 2016 Washipst@ 11 , DC ANNUAL REPORT [X] PURSUANT TO SECTON 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) CHEMED/ROTO-ROOTER SAVINGS & RETIREMENT PLAN (Full
May 23, 2018	EX-24	24 Powers of Attorney EXHIBIT 24 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned, a Director of Chemed Corporation, hereby constitutes and appoints Kevin J.
May 23, 2018	S-8	2018 Stock Incentive Plan SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 255 E. Fifth Street, Suite 2600, Cincinnati, Ohio 45202 (Address of principal ex
May 23, 2018	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 21, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Numbe
April 27, 2018	10-Q	CHE / Chemed Corp. CHEMED CORP. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specif
April 19, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 19, 2018 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other jurisdiction of incorporation) (Commission File Num

CHE / Chemed Corporation - SEC-Einreichungen, Jahresbericht, Proxy Statement

Basisstatistiken

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?

Other Listings